Browse > Article

Monoamine Oxidase Inhibitory Components from the Roots of Sophora flavescens  

Hwang Ji-Sang (College of Pharmacy, Chungbuk National University)
Lee Seon A (College of Pharmacy, Chungbuk National University)
Hong Seong Su (College of Pharmacy, Chungbuk National University)
Lee Kyong Soon (College of Pharmacy, Chungbuk National University)
Lee Myung Koo (College of Pharmacy, Chungbuk National University, Research Center for Bioresource and Health, Chungbuk National University)
Hwang Bang Yeon (College of Pharmacy, Chungbuk National University)
Ro Jai Seup (College of Pharmacy, Chungbuk National University)
Publication Information
Archives of Pharmacal Research / v.28, no.2, 2005 , pp. 190-194 More about this Journal
Abstract
In our search for monoamine oxidase (MAO) inhibitors from natural resources, we found that the methanol extract of the roots of Sophora flavescens showed an inhibitory effect on mouse brain monoamine oxidase (MAO). Bioactivity-guided isolation of the extract yielded two known flavonoids, formononetin (1) and kushenol F (2), as active compounds along with three inactive compounds, oxymatrine (3), trifolirhizin (4), and ${\beta}$-sitosterol (5). Formononetin (1) and kushenol F (2) showed significant inhibitory effects on MAO in a dose-dependent manner with $IC_{50}$ values of 13.2 and $69.9\;{\mu}M$, respectively. Formononetin (1) showed a slightly more potent inhibitory effect against MAO-B ($IC_{50}:\;11.0\;{\mu}M$) than MAO-A ($IC_{50}:\;21.2\;{\mu}M$). Kushenol F (2) also preferentially inhibited the MAO-B activity than MAO-A activity with the $IC_{50}$ values of 63.1 and $103.7\;{\mu}M$, respectively.
Keywords
Sophora flavescens; Leguminosae; Formononetin; Kushenol F; Monoamine oxidase inhibitor;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 15  (Related Records In Web of Science)
Times Cited By SCOPUS : 12
연도 인용수 순위
1 Bach, A. W., Lan, N. C., Johnson, D. L., Abell, C. W., Bembenek, M. E., Kwan, S. W., Seeburg, P. H., and Shih, J. C., cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. U.S.A., 85, 4934-4938 (1988)   DOI
2 Lee, M. K., Hwang, B. Y., Lee, S. A., Oh, G. J., Choi, W. H., Hong, S. S., Lee, K. S., and Ro, J. S., 1-Methyl-2-undecyl- 4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase. Chem. Pharm. Bull., 51, 409-411 (2003)   DOI   ScienceOn
3 Ryu, S. Y., Lee, H. S., Kim, Y. K., and Kim, S. H., Determination of Isoprenyl and lavandulyl positions of flavonoids from Sophora flavescens by NMR experiment. Arch. Pharm. Res., 20, 491-495 (1997)   DOI   ScienceOn
4 Sekine, T., Saito, K., Minami, R., Arai, N., Suzuki, H., Koike, Y., and Murakoshi, I., A new lupin alkaloid, (-)-leontalbinine Noxide, in Sophora flavescens var. angustifolia seeds and its synthesis by biomimetic transformation from (+)-matrine Noxide. Yakugaku Zasshi, 113, 53-62 (1993)   DOI
5 Tang, W. and Eisenbrand, G., Chinese drugs of plant origin. Springer-Verlag, New York, pp. 931-943 (1992)
6 Thull, U., Kneubuhler, S., Testa, B., Borges, M. F. M., and Pinto, M. M. M., Substituted xanthones as selective and reversible monoamine oxidase A inhibitors. Pharm. Res., 10, 1187-1190 (1993)   DOI   ScienceOn
7 Park, J. A., Kim, H. J., Jin, C., Lee, K. T., and Lee, Y. S., A new pterocarpan, (-)-maackiain sulfate, from the roots of Sophora subprostrata. Arch. Pharm. Res., 26, 1009-1013 (2003)   DOI   ScienceOn
8 Naoi, M. and Nagatsu, T., Quinoline and quininaldines as naturally occurring inhibitors specific for type A monoamine oxidase. Life Sci., 40, 1075-1082 (1987)   DOI   ScienceOn
9 Abell, C. W. and Kwan, S. W., Molecular characterization of monoamine oxidase A and B. Prog. Nucl. Acids Res. Mol. Biol., 65, 129-156 (2001)   DOI
10 Jung, B. S. and Shin, M. K., Encyclopedia of illustrated Korean natural drugs. Young Lim Sa, Seoul, pp707-708 (1989)
11 Benedetti, M. S. and Dostert, P., Monoamine oxidase: from physiology and pathophysiology to the design and clinical application of reversible inhibitors. In Testa, B. (Eds.) Advances in Drug Research, vol. 23. Academic Press, New York, pp.65-125 (1992)
12 Ro, J. S., Lee, S. S., Lee, K. S., and Lee, M. K., Inhibition of type A monoamine oxidase by coptisine in mouse brain. Life Sci., 70, 639-645 (2001)   DOI   ScienceOn
13 Lee, S., Kim, K. S, Shim, S. H., Park, Y. M., and Kim, B. K. Constituents from the non-polar fraction of Artemisia apiacea. Arch. Pharm. Res., 26, 902-905 (2003)   DOI   ScienceOn
14 Kalgutkar, A. S., Castagnoli, N. J., and Testa, B., Selective inhibitors of monoamine oxidase as probes of its catalytic site and mechanism. Med. Res. Rev., 4, 325-388 (1995)   DOI   ScienceOn
15 Thomas, T., Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease. Neurobiol. Aging, 21, 343-348 (2000)   DOI   PUBMED   ScienceOn
16 Suzuki, O., Katsumata, Y., Oya, M., Chari, V. M., Vermes, B., Wagner, H., and Hostettmann, K., Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones. Planta Med., 42, 17-21 (1981)   DOI   ScienceOn
17 Jo, Y. S., Huong, D. T., Bae, K., Lee, M. K., and Kim, Y. H., Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium. Planta Med., 68, 84-85 (2002)   DOI   ScienceOn
18 Shih, J. C., Chen, K., and Ridd, M. J., Monoamine oxidase: from genes to behavior. Annu. Rev. Neurosci., 22, 197-217 (1999)   DOI   ScienceOn
19 Yamada, M. and Yasuhara, H., Clinical pharmacology of MAO inhibitors: Safety and future. Nerurotoxicology, 25, 215-221 (2004)   DOI   ScienceOn
20 Kraml, M., A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol., 14, 1684-1686 (1965)   DOI   PUBMED   ScienceOn
21 Wu, L, J., Miyase, T., Ueno, A., Kuroyamagi, M., Noro, T., and Fukushima, S., Studies on the constituents of Sophora flavescens III. Yakugaku Zasshi, 105, 736-741 (1985)   DOI